Venarum Medical LLC

Venarum Medical LLC is a for-profit limited liability company based in Eatontown, New Jersey that specializes in developing medical devices and technologies. It was registered in SAM.gov in July 2015 and is eligible to receive federal contracts and grants through April 2024.

Venarum Medical has received several federal grants to support research and development of innovative medical products. In 2021, the National Science Foundation awarded Venarum a $255,619 grant through the Engineering program to fund a project on "Integrated Manufacturing of Artificial Valves for Medical Use." This nine-month grant enabled R&D activities to advance Venarum's integrated manufacturing techniques for artificial heart valves. Additionally, Venarum has received substantial funding from the Department of Health and Human Services' Food and Drug Administration. In 2020, the FDA provided a $1.66 million grant for the "K9-ICT: A Novel Urethral Valve Treatment for Canine Urinary Incontinence" project, with the goal of developing a catheter-delivered urethral valve system to treat urinary incontinence in dogs. This multi-year project, running until late 2023, aims to optimize the device components, conduct testing, and perform in vivo clinical safety studies. A preceding $167,648 grant in 2020 funded initial work on the same canine urethral valve concept. Through these federal grants, Venarum has advanced the development of medical devices targeting both human and veterinary applications, drawing on its expertise in areas like polymer science, implantable technologies, and manufacturing processes.